Long-term Eculizumab Therapy in a Child With Refractory Immune Complex-Mediated Membranoproliferative Glomerulonephritis

Kidney Int Rep. 2017 Sep 8;3(2):482-485. doi: 10.1016/j.ekir.2017.08.019. eCollection 2018 Mar.

Rahul Chanchlani^{1

2

3}, Paul Thorner^{4

5}, Seetha Radhakrishnan^{1

5}, Diane Hebert^{1

5}, Valerie Langlois^{1

5}, Steven Arora³, David Barth^{6

7}, Daniel Cattran^{6

7}, Michael Kirschfink⁸, Christoph Licht^{1

5

9}

¹ Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada.
² Institute of Health Management, Policy and Evaluation, University of Toronto, Toronto, Ontario, Canada.
³ Division of Nephrology, McMaster Children's Hospital, Hamilton, Ontario, Canada.
⁴ Paediatric Laboratory Medicine, University of Toronto, Toronto, Ontario, Canada.
⁵ Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
⁶ Department of Internal Medicine, University of Toronto, Toronto, Ontario, Canada.
⁷ Division of Nephrology, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.
⁸ Institute for Immunology, University of Heidelberg, Heidelberg, Germany.
⁹ Cell Biology Program, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.

No abstract available

Publication types